Prebiotics in Peritoneal Dialysis

Completed · Not applicable

Conditions studied: End Stage Renal Disease, Gut Microbiome Dysbiosis

In brief

The Prebiotics in Peritoneal Dialysis trial is a non-randomized, open-label, crossover study of p-inulin for patients with end-stage renal disease treated with peritoneal dialysis.

Key facts

Study ID

NCT03265639

Run by

Ali Ramezani

People needed

9

Starts

2016-04-21

Expected to finish

2018-02-28

Last updated by the study team

2018-11-19

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Peritoneal dialysis therapy for end-stage renal disease
• ≥30 days since dialysis initiation
• Ability to provide informed consent

You may not qualify if…

• Use of pre- or pro-biotics during the past 2 months
• Consumption of pro-biotic yogurt during the past 2 weeks
• Use of antibiotics within the past 2 months
• Presence of chronic infection
• Chronic gastrointestinal condition other than constipation
• Cirrhosis or chronic active hepatitis
• Stomach/intestinal resection
• PD access problems
• Anticipated kidney transplant or transfer to another dialysis unit within 9 months
• Expected survival < 9 months
• Pregnancy, anticipated pregnancy, or breastfeeding
• Incarceration
• Participation in another intervention study
• Severe anemia defined as hemoglobin <9.0 g/dl

Where it is running

• DaVita Georgetown Home Training Unit — Washington D.C., District of Columbia, United States
• DaVita K Street — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.